SPONSOR
Federico II University
Total Trials
4
Recruiting
4
Phases
Phase 2, Phase 3
Conditions studied: HypercholesterolemiaSTEMI (ST Elevation MI)Esophagitis, EosinophilicType 1 Diabetes
Federico II University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Hypercholesterolemia, STEMI (ST Elevation MI), Esophagitis, Eosinophilic, Type 1 Diabetes.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Federico II University
How many clinical trials has Federico II University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Federico II University, of which 4 are actively recruiting participants. These trials cover conditions including Hypercholesterolemia, STEMI (ST Elevation MI), Esophagitis, Eosinophilic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Federico II University research focus on?
Federico II University clinical trials span Hypercholesterolemia, STEMI (ST Elevation MI), Esophagitis, Eosinophilic, Type 1 Diabetes. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Federico II University clinical trial?
To participate in a Federico II University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Federico II University trials with current recruitment status updated daily.
Clinical Trials by Federico II University
NCT07374861
Recruiting
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
Hypercholesterolemia
NCT07380919 Phase 2, Phase 3
Recruiting
Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
STEMI (ST Elevation MI)
NCT06093204
Recruiting
The Potential Role of Compounds Derived From Ultra-processed Foods in Pathogenesis of Eosinophilic Esophagitis
Esophagitis, Eosinophilic
NCT05936242
Recruiting
Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
Type 1 Diabetes
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology